SANJIVANI PARANTERAL Financial Statement Analysis
|
||
|
The Revenues of SANJIVANI PARANTERAL have increased by 28.83% YoY .
The Earnings Per Share (EPS) of SANJIVANI PARANTERAL has increased by 28.98 % YoY. |
||
SANJIVANI PARANTERAL Last 5 Annual Financial Results
[BOM: 531569]
| Consolidated | Mar2025 | Mar2024 |
|---|---|---|
| Revenues | ₹70 Cr | ₹54 Cr |
| Expenses | ₹60 Cr | ₹46 Cr |
| Operating Profit (Excl OI) | ₹10 Cr | ₹8.02 Cr |
| Other Income | ₹1.29 Cr | ₹0.74 Cr |
| Interest | ₹0.59 Cr | ₹0.25 Cr |
| Depreciation | ₹0.62 Cr | ₹0.93 Cr |
| Profit Before Tax | ₹10 Cr | ₹7.57 Cr |
| Profit After Tax | ₹8.09 Cr | ₹6.17 Cr |
| Consolidated Net Profit | ₹8.10 Cr | ₹6.17 Cr |
| Earnings Per Share (Rs) | ₹6.81 | ₹5.28 |
| PAT Margin (%) | 11.13 | 11.31 |
| ROE(%) | 25.90 | 23.83 |
| ROCE(%) | 29.18 | 27.11 |
| Total Debt/Equity(x) | 0.22 | 0.04 |
Key Financials |
||
| Market Cap | : | ₹ 231.2 Cr |
| Revenue (TTM) | : | ₹ 68.7 Cr |
| Net Profit(TTM) | : | ₹ 6.7 Cr |
| EPS (TTM) | : | ₹ 5.4 |
| P/E (TTM) | : | 34.6 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SANJIVANI PARANTERAL | 17.2% | 35.1% | -7.3% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.1% | 0.5% | 14% |
| DIVIS LABORATORIES | -0.9% | 21.1% | 25.6% |
| TORRENT PHARMACEUTICALS | -1.3% | 1.1% | 32.7% |
| CIPLA | 0.2% | 2.1% | -5.1% |
| DR REDDYS LABORATORIES | 0.2% | -7.7% | -7.5% |
| MANKIND PHARMA | -1.4% | -3.7% | -5.3% |
| LUPIN | -0.7% | -5.7% | 24% |
| ZYDUS LIFESCIENCES | -0.1% | -3.9% | 14.1% |
SANJIVANI PARANTERAL Revenues
[BOM: 531569]
| Y-o-Y | 28.83 % |
| 5 Yr CAGR | 28.83 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹70 Cr | 28.83 | |
| Mar2024 | ₹54 Cr | - | |
SANJIVANI PARANTERAL Operating Profit
[BOM: 531569]
| Y-o-Y | 28.26 % |
| 5 Yr CAGR | 28.26 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹10 Cr | 28.26 | |
| Mar2024 | ₹8.02 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -0.48 % |
| 5 Yr CAGR | -0.48 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 14.66% | -0.48 | |
| Mar2024 | 14.73% | - | |
SANJIVANI PARANTERAL Profit After Tax
[BOM: 531569]
| Y-o-Y | 31.34 % |
| 5 Yr CAGR | 31.34 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹8.10 Cr | 31.34 | |
| Mar2024 | ₹6.17 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -1.59 % |
| 5 Yr CAGR | -1.59 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 11.13 % | -1.59 | |
| Mar2024 | 11.31 % | - | |
SANJIVANI PARANTERAL Earnings Per Share (EPS)
[BOM: 531569]
| Y-o-Y | 28.98 % |
| 5 Yr CAGR | 28.98 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹6.81 | 28.98 | |
| Mar2024 | ₹5.28 | - | |
SANJIVANI PARANTERAL Return on Capital Employed (ROCE)
[BOM: 531569]
| Y-o-Y | 7.64 % |
| 5 Yr CAGR | 7.64 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 29.18% | 7.64 | |
| Mar2024 | 27.11% | - | |
SANJIVANI PARANTERAL Share Price vs Sensex
| Current Share Price | : | ₹188.0 |
| Current MarketCap | : | ₹ 231.2 Cr |
| Updated EOD on | : | Aug 10,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SANJIVANI PARANTERAL | 17.2% |
35.1% |
-7.3% |
| SENSEX | -0.1% |
2.4% |
-3.3% |
SANJIVANI PARANTERAL related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about SANJIVANI PARANTERAL Financials
How the annual revenues of SANJIVANI PARANTERAL have changed ?
The Revenues of SANJIVANI PARANTERAL have increased by 28.83% YoY .
How the Earnings per Share (EPS) of SANJIVANI PARANTERAL have changed?
The Earnings Per Share (EPS) of SANJIVANI PARANTERAL has increased by 28.98 % YoY .
Check out Intrinsic Value of Peers of SANJIVANI PARANTERAL
Compare Stock Analytics of Peers of SANJIVANI PARANTERAL
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
